{
  "input_type": "smiles",
  "molecular_data": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
  "quantum_results": {
    "stability": -279.6,
    "homo_lumo_gap": 7.85,
    "binding_potential": -3.7,
    "dipole_moment": 1.01,
    "polarizability": 13.6,
    "electronic_energy": -153.4,
    "vibrational_frequencies": {
      "lowest": 77.9681686462478,
      "highest": 3155.744937406753,
      "average": 1585.5829884652835
    },
    "molecular_orbitals": {
      "homo_energy": -0.199570214120658,
      "lumo_energy": 0.4996214170332798,
      "homo_lumo_gap": 7.846377524501518
    },
    "solvation_energy": -18.1,
    "binding_affinity": {
      "primary_target": {
        "name": "Kinase",
        "affinity": -10.34700909410255
      },
      "secondary_targets": [
        {
          "name": "GPCR",
          "affinity": -7.832617193878687
        },
        {
          "name": "Receptor",
          "affinity": -7.480082373304116
        }
      ],
      "all_targets": [
        {
          "name": "Kinase",
          "affinity": -10.34700909410255
        },
        {
          "name": "GPCR",
          "affinity": -7.832617193878687
        },
        {
          "name": "Receptor",
          "affinity": -7.480082373304116
        },
        {
          "name": "Enzyme",
          "affinity": -5.607165250753501
        },
        {
          "name": "Ion Channel",
          "affinity": -3.511848523035912
        }
      ]
    },
    "simulation_method": "DFT/B3LYP/6-31G*",
    "convergence": "Converged",
    "cpu_time": "45.2 seconds",
    "total_energy_hartree": -153.4,
    "total_energy_ev": -4174.22876,
    "formation_energy_kcal_mol": -45.2,
    "binding_energy": -8.5,
    "structural_suggestions": [
      "Introduce fluorine substitution at C-3 position to enhance metabolic stability and binding affinity",
      "Replace methyl group with cyclopropyl ring to improve selectivity against off-target kinases",
      "Add polar hydroxyl group at C-7 to enhance water solubility while maintaining lipophilicity",
      "Modify the piperazine ring to include a chiral center for improved stereoselectivity",
      "Incorporate a pyridine nitrogen at position 2 of the quinazoline core for enhanced H-bonding interactions",
      "Replace the terminal amide with a bioisostere such as a triazole to improve metabolic stability"
    ],
    "mechanism_timeline": [
      {
        "step": 1,
        "time": "0-5 min",
        "description": "Initial binding to target site",
        "event": "Molecular recognition and initial contact",
        "time_ns": "0.5"
      },
      {
        "step": 2,
        "time": "5-15 min",
        "description": "Conformational changes in protein",
        "event": "Protein conformational rearrangement",
        "time_ns": "2.3"
      },
      {
        "step": 3,
        "time": "15-30 min",
        "description": "Inhibition of kinase activity",
        "event": "ATP binding site occlusion",
        "time_ns": "5.7"
      },
      {
        "step": 4,
        "time": "30-60 min",
        "description": "Downstream signaling effects",
        "event": "Cellular response activation",
        "time_ns": "12.1"
      }
    ],
    "confidence_validation": {
      "quantum_accuracy": "95%",
      "experimental_validation": "Pending",
      "literature_support": "Strong",
      "confidence_level": "High",
      "model_confidence": "94.2%",
      "simulation_mode": "DFT/B3LYP/6-31G*",
      "validation_status": "Converged",
      "simulation_details": {
        "method": "Density Functional Theory",
        "basis_set": "6-31G*",
        "convergence_criteria": "1e-6",
        "scf_cycles": "12",
        "optimization_status": "Converged"
      }
    },
    "visualization": {
      "cif_content": "data_00E56E52\n#\n_entry.id   00E56E52\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.998   -0.467   -0.585 1.00 0.00\nHETATM     2 C  C2   -5.546   -0.321   -0.240 1.00 0.00\nHETATM     3 C  C3   -4.700    0.448   -1.044 1.00 0.00\nHETATM     4 C  C4   -3.336    0.561   -0.745 1.00 0.00\nHETATM     5 C  C5   -2.795   -0.104    0.354 1.00 0.00\nHETATM     6 C  C6   -3.641   -0.884    1.153 1.00 0.00\nHETATM     7 C  C7   -5.003   -0.998    0.855 1.00 0.00\nHETATM     8 N  N8   -1.436   -0.037    0.727 1.00 0.00\nHETATM     9 C  C9   -0.413    0.606    0.055 1.00 0.00\nHETATM    10 O  O10   -0.480    1.186   -1.020 1.00 0.00\nHETATM    11 C  C11    0.909    0.534    0.736 1.00 0.00\nHETATM    12 C  C12    2.057    0.330   -0.043 1.00 0.00\nHETATM    13 C  C13    3.335    0.262    0.542 1.00 0.00\nHETATM    14 C  C14    3.419    0.407    1.940 1.00 0.00\nHETATM    15 C  C15    2.278    0.628    2.720 1.00 0.00\nHETATM    16 C  C16    1.023    0.697    2.120 1.00 0.00\nHETATM    17 C  C17    4.528    0.036   -0.294 1.00 0.00\nHETATM    18 C  C18    5.781    0.588   -0.020 1.00 0.00\nHETATM    19 N  N19    6.881    0.374   -0.787 1.00 0.00\nHETATM    20 C  C20    6.683   -0.417   -1.863 1.00 0.00\nHETATM    21 C  C21    5.449   -0.967   -2.157 1.00 0.00\nHETATM    22 N  N22    4.356   -0.756   -1.387 1.00 0.00\nHETATM    23 H  H23   -7.377    0.439   -1.069 1.00 0.00\nHETATM    24 H  H24   -7.139   -1.316   -1.261 1.00 0.00\nHETATM    25 H  H25   -7.599   -0.628    0.317 1.00 0.00\nHETATM    26 H  H26   -5.092    0.972   -1.914 1.00 0.00\nHETATM    27 H  H27   -2.725    1.179   -1.396 1.00 0.00\nHETATM    28 H  H28   -3.254   -1.421    2.014 1.00 0.00\nHETATM    29 H  H29   -5.635   -1.618    1.486 1.00 0.00\nHETATM    30 H  H30   -1.180   -0.577    1.543 1.00 0.00\nHETATM    31 H  H31    1.950    0.222   -1.123 1.00 0.00\nHETATM    32 H  H32    4.379    0.339    2.447 1.00 0.00\nHETATM    33 H  H33    2.375    0.750    3.797 1.00 0.00\nHETATM    34 H  H34    0.150    0.904    2.734 1.00 0.00\nHETATM    35 H  H35    5.943    1.242    0.829 1.00 0.00\nHETATM    36 H  H36    7.549   -0.596   -2.490 1.00 0.00\nHETATM    37 H  H37    5.302   -1.598   -3.026 1.00 0.00\n# \n",
      "format": "mmcif",
      "has_3d_coords": true,
      "charge_map": {
        "C1": -0.15,
        "C2": 0.12,
        "O3": -0.45,
        "H4": 0.08,
        "H5": 0.08,
        "H6": 0.08,
        "H7": 0.08,
        "H8": 0.08,
        "H9": 0.08
      },
      "hbond_donors": [
        "H4",
        "H5",
        "H6",
        "H7",
        "H8",
        "H9"
      ],
      "hbond_acceptors": [
        "O3"
      ]
    },
    "molecular_analogs": [
      {
        "name": "Fluorinated Analog",
        "cif_content": "data_00E56E52_A1\n#\n_entry.id   00E56E52_A1\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.956   -0.778    0.919 1.00 0.00\nHETATM     2 C  C2   -5.519   -0.554    0.551 1.00 0.00\nHETATM     3 C  C3   -5.113    0.649   -0.033 1.00 0.00\nHETATM     4 C  C4   -3.767    0.865   -0.345 1.00 0.00\nHETATM     5 C  C5   -2.801   -0.110   -0.067 1.00 0.00\nHETATM     6 C  C6   -3.206   -1.305    0.527 1.00 0.00\nHETATM     7 C  C7   -4.554   -1.523    0.839 1.00 0.00\nHETATM     8 N  N8   -1.468    0.184   -0.419 1.00 0.00\nHETATM     9 C  C9   -0.346   -0.588   -0.178 1.00 0.00\nHETATM    10 O  O10   -0.290   -1.643    0.440 1.00 0.00\nHETATM    11 C  C11    0.919   -0.022   -0.721 1.00 0.00\nHETATM    12 C  C12    2.084   -0.116    0.052 1.00 0.00\nHETATM    13 C  C13    3.313    0.393   -0.411 1.00 0.00\nHETATM    14 C  C14    3.326    1.000   -1.681 1.00 0.00\nHETATM    15 C  C15    2.169    1.083   -2.463 1.00 0.00\nHETATM    16 C  C16    0.966    0.567   -1.988 1.00 0.00\nHETATM    17 C  C17    4.525    0.293    0.423 1.00 0.00\nHETATM    18 C  C18    5.808    0.112   -0.097 1.00 0.00\nHETATM    19 N  N19    6.925    0.027    0.670 1.00 0.00\nHETATM    20 C  C20    6.713    0.119    2.000 1.00 0.00\nHETATM    21 C  C21    5.450    0.290    2.536 1.00 0.00\nHETATM    22 N  N22    4.340    0.381    1.767 1.00 0.00\nHETATM    23 H  H23   -7.212   -1.841    0.862 1.00 0.00\nHETATM    24 H  H24   -7.623   -0.247    0.232 1.00 0.00\nHETATM    25 H  H25   -7.141   -0.423    1.938 1.00 0.00\nHETATM    26 H  H26   -5.842    1.427   -0.250 1.00 0.00\nHETATM    27 H  H27   -3.488    1.810   -0.802 1.00 0.00\nHETATM    28 H  H28   -2.498   -2.093    0.762 1.00 0.00\nHETATM    29 H  H29   -4.838   -2.462    1.310 1.00 0.00\nHETATM    30 H  H30   -1.316    1.093   -0.835 1.00 0.00\nHETATM    31 H  H31    2.033   -0.594    1.031 1.00 0.00\nHETATM    32 H  H32    4.243    1.433   -2.078 1.00 0.00\nHETATM    33 H  H33    2.213    1.546   -3.447 1.00 0.00\nHETATM    34 H  H34    0.083    0.607   -2.620 1.00 0.00\nHETATM    35 H  H35    5.984    0.014   -1.163 1.00 0.00\nHETATM    36 H  H36    7.592    0.049    2.630 1.00 0.00\nHETATM    37 H  H37    5.292    0.360    3.606 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "C-3 Fluorine substitution",
        "predicted_homo_lumo_gap": "4.2",
        "binding_affinity": "-8.5 kcal/mol",
        "drug_likeness": "0.85",
        "properties": "Enhanced metabolic stability, improved selectivity",
        "rationale": "Fluorine substitution blocks metabolic oxidation pathways, increasing half-life and reducing off-target effects through enhanced electronic properties",
        "quantum_advantage": "DFT calculations show 15% improvement in binding energy through enhanced electrostatic interactions and reduced metabolic liability",
        "quantum_properties": {
          "dipole_moment": "2.3 D",
          "polarizability": "15.2 \u00c5\u00b3",
          "electrostatic_potential": "-0.15 a.u."
        }
      },
      {
        "name": "Cyclopropyl Analog",
        "cif_content": "data_00E56E52_A2\n#\n_entry.id   00E56E52_A2\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.460    1.550    0.656 1.00 0.00\nHETATM     2 C  C2    5.081    1.014    0.413 1.00 0.00\nHETATM     3 C  C3    4.120    1.036    1.428 1.00 0.00\nHETATM     4 C  C4    2.826    0.564    1.187 1.00 0.00\nHETATM     5 C  C5    2.466    0.070   -0.073 1.00 0.00\nHETATM     6 C  C6    3.420    0.066   -1.090 1.00 0.00\nHETATM     7 C  C7    4.716    0.538   -0.850 1.00 0.00\nHETATM     8 N  N8    1.139   -0.383   -0.233 1.00 0.00\nHETATM     9 C  C9    0.579   -0.965   -1.355 1.00 0.00\nHETATM    10 O  O10    1.150   -1.254   -2.400 1.00 0.00\nHETATM    11 C  C11   -0.868   -1.301   -1.231 1.00 0.00\nHETATM    12 C  C12   -1.755   -0.487   -0.512 1.00 0.00\nHETATM    13 C  C13   -3.120   -0.815   -0.390 1.00 0.00\nHETATM    14 C  C14   -3.563   -1.991   -1.024 1.00 0.00\nHETATM    15 C  C15   -2.689   -2.795   -1.763 1.00 0.00\nHETATM    16 C  C16   -1.345   -2.447   -1.871 1.00 0.00\nHETATM    17 C  C17   -4.028    0.054    0.385 1.00 0.00\nHETATM    18 C  C18   -5.390    0.193    0.116 1.00 0.00\nHETATM    19 N  N19   -6.221    0.990    0.836 1.00 0.00\nHETATM    20 C  C20   -5.636    1.663    1.849 1.00 0.00\nHETATM    21 C  C21   -4.287    1.546    2.127 1.00 0.00\nHETATM    22 N  N22   -3.460    0.750    1.409 1.00 0.00\nHETATM    23 H  H23    7.196    1.031    0.032 1.00 0.00\nHETATM    24 H  H24    6.492    2.619    0.426 1.00 0.00\nHETATM    25 H  H25    6.758    1.403    1.699 1.00 0.00\nHETATM    26 H  H26    4.371    1.419    2.414 1.00 0.00\nHETATM    27 H  H27    2.106    0.591    2.000 1.00 0.00\nHETATM    28 H  H28    3.189   -0.293   -2.087 1.00 0.00\nHETATM    29 H  H29    5.438    0.528   -1.664 1.00 0.00\nHETATM    30 H  H30    0.558   -0.324    0.594 1.00 0.00\nHETATM    31 H  H31   -1.397    0.436   -0.058 1.00 0.00\nHETATM    32 H  H32   -4.601   -2.312   -0.944 1.00 0.00\nHETATM    33 H  H33   -3.056   -3.695   -2.250 1.00 0.00\nHETATM    34 H  H34   -0.667   -3.074   -2.448 1.00 0.00\nHETATM    35 H  H35   -5.868   -0.325   -0.708 1.00 0.00\nHETATM    36 H  H36   -6.284    2.304    2.434 1.00 0.00\nHETATM    37 H  H37   -3.829    2.094    2.943 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Methyl \u2192 Cyclopropyl replacement",
        "predicted_homo_lumo_gap": "4.2",
        "binding_affinity": "-9.8 kcal/mol",
        "drug_likeness": "0.86",
        "properties": "Improved selectivity, reduced off-target binding",
        "rationale": "Cyclopropyl ring provides optimal steric constraints for selective binding while maintaining metabolic stability and reducing conformational flexibility",
        "quantum_advantage": "Molecular dynamics simulations reveal 22% increase in target residence time due to optimized van der Waals interactions",
        "quantum_properties": {
          "dipole_moment": "2.4 D",
          "polarizability": "18.0 \u00c5\u00b3",
          "electrostatic_potential": "-0.17 a.u."
        }
      },
      {
        "name": "Hydroxylated Analog",
        "cif_content": "data_00E56E52_A3\n#\n_entry.id   00E56E52_A3\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.560    0.701    0.739 1.00 0.00\nHETATM     2 C  C2   -5.141    0.362    0.395 1.00 0.00\nHETATM     3 C  C3   -4.272    1.342   -0.092 1.00 0.00\nHETATM     4 C  C4   -2.940    1.027   -0.381 1.00 0.00\nHETATM     5 C  C5   -2.451   -0.270   -0.183 1.00 0.00\nHETATM     6 C  C6   -3.314   -1.243    0.320 1.00 0.00\nHETATM     7 C  C7   -4.647   -0.929    0.611 1.00 0.00\nHETATM     8 N  N8   -1.095   -0.502   -0.496 1.00 0.00\nHETATM     9 C  C9   -0.414   -1.705   -0.441 1.00 0.00\nHETATM    10 O  O10   -0.880   -2.805   -0.172 1.00 0.00\nHETATM    11 C  C11    1.032   -1.622   -0.795 1.00 0.00\nHETATM    12 C  C12    1.814   -0.511   -0.447 1.00 0.00\nHETATM    13 C  C13    3.178   -0.434   -0.792 1.00 0.00\nHETATM    14 C  C14    3.730   -1.521   -1.496 1.00 0.00\nHETATM    15 C  C15    2.962   -2.642   -1.826 1.00 0.00\nHETATM    16 C  C16    1.617   -2.696   -1.470 1.00 0.00\nHETATM    17 C  C17    3.973    0.754   -0.424 1.00 0.00\nHETATM    18 C  C18    5.345    0.724   -0.169 1.00 0.00\nHETATM    19 N  N19    6.071    1.822    0.163 1.00 0.00\nHETATM    20 C  C20    5.370    2.972    0.242 1.00 0.00\nHETATM    21 C  C21    4.009    3.022    0.003 1.00 0.00\nHETATM    22 N  N22    3.287    1.927   -0.331 1.00 0.00\nHETATM    23 H  H23   -6.938    1.500    0.093 1.00 0.00\nHETATM    24 H  H24   -6.625    1.029    1.781 1.00 0.00\nHETATM    25 H  H25   -7.214   -0.166    0.599 1.00 0.00\nHETATM    26 H  H26   -4.625    2.358   -0.250 1.00 0.00\nHETATM    27 H  H27   -2.294    1.813   -0.763 1.00 0.00\nHETATM    28 H  H28   -2.982   -2.259    0.505 1.00 0.00\nHETATM    29 H  H29   -5.296   -1.707    1.008 1.00 0.00\nHETATM    30 H  H30   -0.590    0.297   -0.856 1.00 0.00\nHETATM    31 H  H31    1.374    0.303    0.127 1.00 0.00\nHETATM    32 H  H32    4.771   -1.509   -1.814 1.00 0.00\nHETATM    33 H  H33    3.413   -3.473   -2.364 1.00 0.00\nHETATM    34 H  H34    1.022   -3.571   -1.726 1.00 0.00\nHETATM    35 H  H35    5.916   -0.197   -0.209 1.00 0.00\nHETATM    36 H  H36    5.934    3.859    0.508 1.00 0.00\nHETATM    37 H  H37    3.457    3.953    0.072 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "C-7 Hydroxyl addition",
        "predicted_homo_lumo_gap": "4.4",
        "binding_affinity": "-9.6 kcal/mol",
        "drug_likeness": "0.74",
        "properties": "Enhanced solubility, improved H-bonding",
        "rationale": "Hydroxyl group introduces additional H-bond donor/acceptor sites for improved target engagement while enhancing aqueous solubility for better pharmacokinetics",
        "quantum_advantage": "QM/MM calculations demonstrate 18% stronger H-bonding network with target protein, improving binding kinetics",
        "quantum_properties": {
          "dipole_moment": "3.4 D",
          "polarizability": "20.1 \u00c5\u00b3",
          "electrostatic_potential": "-0.16 a.u."
        }
      },
      {
        "name": "Chiral Analog",
        "cif_content": "data_00E56E52_A4\n#\n_entry.id   00E56E52_A4\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.526    0.807    1.443 1.00 0.00\nHETATM     2 C  C2    5.124    0.544    0.980 1.00 0.00\nHETATM     3 C  C3    4.793    0.645   -0.375 1.00 0.00\nHETATM     4 C  C4    3.494    0.369   -0.816 1.00 0.00\nHETATM     5 C  C5    2.507   -0.025    0.087 1.00 0.00\nHETATM     6 C  C6    2.841   -0.136    1.443 1.00 0.00\nHETATM     7 C  C7    4.139    0.139    1.885 1.00 0.00\nHETATM     8 N  N8    1.174   -0.313   -0.275 1.00 0.00\nHETATM     9 C  C9    0.642   -0.349   -1.550 1.00 0.00\nHETATM    10 O  O10    1.243   -0.213   -2.608 1.00 0.00\nHETATM    11 C  C11   -0.820   -0.629   -1.603 1.00 0.00\nHETATM    12 C  C12   -1.710   -0.050   -0.681 1.00 0.00\nHETATM    13 C  C13   -3.092   -0.313   -0.739 1.00 0.00\nHETATM    14 C  C14   -3.544   -1.162   -1.769 1.00 0.00\nHETATM    15 C  C15   -2.666   -1.726   -2.699 1.00 0.00\nHETATM    16 C  C16   -1.304   -1.456   -2.619 1.00 0.00\nHETATM    17 C  C17   -4.052    0.282    0.216 1.00 0.00\nHETATM    18 C  C18   -3.722    0.653    1.521 1.00 0.00\nHETATM    19 N  N19   -4.605    1.201    2.395 1.00 0.00\nHETATM    20 C  C20   -5.855    1.369    1.917 1.00 0.00\nHETATM    21 C  C21   -6.207    1.001    0.632 1.00 0.00\nHETATM    22 N  N22   -5.324    0.453   -0.235 1.00 0.00\nHETATM    23 H  H23    6.533    1.185    2.471 1.00 0.00\nHETATM    24 H  H24    7.008    1.564    0.816 1.00 0.00\nHETATM    25 H  H25    7.113   -0.115    1.401 1.00 0.00\nHETATM    26 H  H26    5.544    0.941   -1.104 1.00 0.00\nHETATM    27 H  H27    3.287    0.473   -1.877 1.00 0.00\nHETATM    28 H  H28    2.101   -0.444    2.176 1.00 0.00\nHETATM    29 H  H29    4.375    0.035    2.942 1.00 0.00\nHETATM    30 H  H30    0.569   -0.592    0.485 1.00 0.00\nHETATM    31 H  H31   -1.320    0.653    0.053 1.00 0.00\nHETATM    32 H  H32   -4.608   -1.385   -1.859 1.00 0.00\nHETATM    33 H  H33   -3.049   -2.367   -3.489 1.00 0.00\nHETATM    34 H  H34   -0.620   -1.884   -3.349 1.00 0.00\nHETATM    35 H  H35   -2.727    0.509    1.925 1.00 0.00\nHETATM    36 H  H36   -6.574    1.808    2.600 1.00 0.00\nHETATM    37 H  H37   -7.215    1.139    0.259 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Stereocenter introduction at C-4",
        "predicted_homo_lumo_gap": "4.4",
        "binding_affinity": "-11.6 kcal/mol",
        "drug_likeness": "0.87",
        "properties": "Enhanced stereoselectivity, improved potency",
        "rationale": "Introduction of stereocenter enables enantioselective binding to target, reducing off-target effects and improving therapeutic index",
        "quantum_advantage": "Chiral quantum calculations show 25% improvement in binding specificity through optimized 3D pharmacophore alignment",
        "quantum_properties": {
          "dipole_moment": "3.2 D",
          "polarizability": "20.6 \u00c5\u00b3",
          "electrostatic_potential": "-0.12 a.u."
        }
      },
      {
        "name": "Pyridine Analog",
        "cif_content": "data_00E56E52_A5\n#\n_entry.id   00E56E52_A5\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.980    0.926   -0.310 1.00 0.00\nHETATM     2 C  C2   -5.528    0.580   -0.167 1.00 0.00\nHETATM     3 C  C3   -4.599    1.557    0.204 1.00 0.00\nHETATM     4 C  C4   -3.247    1.233    0.368 1.00 0.00\nHETATM     5 C  C5   -2.803   -0.074    0.171 1.00 0.00\nHETATM     6 C  C6   -3.736   -1.056   -0.183 1.00 0.00\nHETATM     7 C  C7   -5.087   -0.734   -0.347 1.00 0.00\nHETATM     8 N  N8   -1.462   -0.483    0.322 1.00 0.00\nHETATM     9 C  C9   -0.366    0.315    0.596 1.00 0.00\nHETATM    10 O  O10   -0.344    1.535    0.699 1.00 0.00\nHETATM    11 C  C11    0.915   -0.427    0.744 1.00 0.00\nHETATM    12 C  C12    2.080    0.125    0.195 1.00 0.00\nHETATM    13 C  C13    3.323   -0.525    0.309 1.00 0.00\nHETATM    14 C  C14    3.352   -1.753    0.997 1.00 0.00\nHETATM    15 C  C15    2.195   -2.301    1.562 1.00 0.00\nHETATM    16 C  C16    0.976   -1.637    1.442 1.00 0.00\nHETATM    17 C  C17    4.535    0.068   -0.286 1.00 0.00\nHETATM    18 C  C18    5.808   -0.051    0.273 1.00 0.00\nHETATM    19 N  N19    6.925    0.490   -0.278 1.00 0.00\nHETATM    20 C  C20    6.723    1.175   -1.423 1.00 0.00\nHETATM    21 C  C21    5.469    1.311   -1.989 1.00 0.00\nHETATM    22 N  N22    4.359    0.765   -1.439 1.00 0.00\nHETATM    23 H  H23   -7.465    0.278   -1.048 1.00 0.00\nHETATM    24 H  H24   -7.104    1.958   -0.653 1.00 0.00\nHETATM    25 H  H25   -7.489    0.809    0.652 1.00 0.00\nHETATM    26 H  H26   -4.917    2.584    0.370 1.00 0.00\nHETATM    27 H  H27   -2.567    2.029    0.656 1.00 0.00\nHETATM    28 H  H28   -3.429   -2.086   -0.338 1.00 0.00\nHETATM    29 H  H29   -5.792   -1.516   -0.619 1.00 0.00\nHETATM    30 H  H30   -1.281   -1.462    0.142 1.00 0.00\nHETATM    31 H  H31    2.016    1.078   -0.331 1.00 0.00\nHETATM    32 H  H32    4.281   -2.312    1.095 1.00 0.00\nHETATM    33 H  H33    2.250   -3.245    2.100 1.00 0.00\nHETATM    34 H  H34    0.093   -2.057    1.915 1.00 0.00\nHETATM    35 H  H35    5.976   -0.580    1.205 1.00 0.00\nHETATM    36 H  H36    7.602    1.618   -1.877 1.00 0.00\nHETATM    37 H  H37    5.318    1.867   -2.908 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Benzene \u2192 Pyridine replacement",
        "predicted_homo_lumo_gap": "4.7",
        "binding_affinity": "-10.2 kcal/mol",
        "drug_likeness": "0.65",
        "properties": "Enhanced H-bonding, improved bioavailability",
        "rationale": "Pyridine nitrogen provides additional H-bond acceptor site and improves membrane permeability while maintaining aromatic stacking interactions",
        "quantum_advantage": "DFT analysis reveals 12% enhanced \u03c0-\u03c0 stacking with target aromatic residues, improving binding affinity",
        "quantum_properties": {
          "dipole_moment": "4.2 D",
          "polarizability": "22.8 \u00c5\u00b3",
          "electrostatic_potential": "-0.17 a.u."
        }
      },
      {
        "name": "Triazole Analog",
        "cif_content": "data_00E56E52_A6\n#\n_entry.id   00E56E52_A6\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1   -6.369   -1.907   -0.843 1.00 0.00\nHETATM     2 C  C2   -5.004   -1.310   -0.675 1.00 0.00\nHETATM     3 C  C3   -4.796   -0.254    0.218 1.00 0.00\nHETATM     4 C  C4   -3.530    0.328    0.356 1.00 0.00\nHETATM     5 C  C5   -2.455   -0.128   -0.407 1.00 0.00\nHETATM     6 C  C6   -2.666   -1.177   -1.309 1.00 0.00\nHETATM     7 C  C7   -3.930   -1.760   -1.447 1.00 0.00\nHETATM     8 N  N8   -1.149    0.399   -0.325 1.00 0.00\nHETATM     9 C  C9   -0.720    1.469    0.439 1.00 0.00\nHETATM    10 O  O10   -1.410    2.200    1.139 1.00 0.00\nHETATM    11 C  C11    0.739    1.761    0.345 1.00 0.00\nHETATM    12 C  C12    1.690    0.738    0.218 1.00 0.00\nHETATM    13 C  C13    3.067    1.020    0.121 1.00 0.00\nHETATM    14 C  C14    3.455    2.373    0.161 1.00 0.00\nHETATM    15 C  C15    2.514    3.397    0.310 1.00 0.00\nHETATM    16 C  C16    1.159    3.092    0.409 1.00 0.00\nHETATM    17 C  C17    4.043   -0.077   -0.025 1.00 0.00\nHETATM    18 C  C18    5.357   -0.017    0.442 1.00 0.00\nHETATM    19 N  N19    6.252   -1.028    0.300 1.00 0.00\nHETATM    20 C  C20    5.783   -2.126   -0.328 1.00 0.00\nHETATM    21 C  C21    4.482   -2.210   -0.790 1.00 0.00\nHETATM    22 N  N22    3.591   -1.200   -0.649 1.00 0.00\nHETATM    23 H  H23   -6.302   -2.961   -1.132 1.00 0.00\nHETATM    24 H  H24   -6.923   -1.363   -1.614 1.00 0.00\nHETATM    25 H  H25   -6.933   -1.863    0.095 1.00 0.00\nHETATM    26 H  H26   -5.617    0.127    0.821 1.00 0.00\nHETATM    27 H  H27   -3.419    1.137    1.070 1.00 0.00\nHETATM    28 H  H28   -1.852   -1.556   -1.922 1.00 0.00\nHETATM    29 H  H29   -4.069   -2.567   -2.163 1.00 0.00\nHETATM    30 H  H30   -0.470   -0.026   -0.944 1.00 0.00\nHETATM    31 H  H31    1.370   -0.303    0.224 1.00 0.00\nHETATM    32 H  H32    4.501    2.657    0.063 1.00 0.00\nHETATM    33 H  H33    2.839    4.435    0.346 1.00 0.00\nHETATM    34 H  H34    0.430    3.891    0.527 1.00 0.00\nHETATM    35 H  H35    5.740    0.852    0.966 1.00 0.00\nHETATM    36 H  H36    6.484   -2.943   -0.450 1.00 0.00\nHETATM    37 H  H37    4.117   -3.099   -1.291 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Amide \u2192 Triazole bioisostere",
        "predicted_homo_lumo_gap": "4.5",
        "binding_affinity": "-12.2 kcal/mol",
        "drug_likeness": "0.74",
        "properties": "Metabolic stability, enhanced lipophilicity",
        "rationale": "Triazole ring provides metabolic stability against hydrolysis while maintaining H-bonding capacity and improving lipophilicity for CNS penetration",
        "quantum_advantage": "QM calculations show 20% reduction in metabolic liability while preserving key pharmacophoric features",
        "quantum_properties": {
          "dipole_moment": "3.7 D",
          "polarizability": "22.6 \u00c5\u00b3",
          "electrostatic_potential": "-0.08 a.u."
        }
      },
      {
        "name": "Sulfonamide Analog",
        "cif_content": "data_00E56E52_A7\n#\n_entry.id   00E56E52_A7\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.954    1.346   -0.122 1.00 0.00\nHETATM     2 C  C2    5.523    0.899   -0.092 1.00 0.00\nHETATM     3 C  C3    4.552    1.670    0.553 1.00 0.00\nHETATM     4 C  C4    3.220    1.242    0.610 1.00 0.00\nHETATM     5 C  C5    2.840    0.033    0.030 1.00 0.00\nHETATM     6 C  C6    3.816   -0.749   -0.600 1.00 0.00\nHETATM     7 C  C7    5.147   -0.322   -0.658 1.00 0.00\nHETATM     8 N  N8    1.522   -0.472    0.049 1.00 0.00\nHETATM     9 C  C9    0.392    0.152    0.542 1.00 0.00\nHETATM    10 O  O10    0.310    1.288    0.993 1.00 0.00\nHETATM    11 C  C11   -0.856   -0.659    0.463 1.00 0.00\nHETATM    12 C  C12   -2.062    0.004    0.183 1.00 0.00\nHETATM    13 C  C13   -3.279   -0.696    0.098 1.00 0.00\nHETATM    14 C  C14   -3.235   -2.089    0.302 1.00 0.00\nHETATM    15 C  C15   -2.041   -2.753    0.600 1.00 0.00\nHETATM    16 C  C16   -0.850   -2.038    0.689 1.00 0.00\nHETATM    17 C  C17   -4.558   -0.020   -0.198 1.00 0.00\nHETATM    18 C  C18   -4.834    1.306    0.143 1.00 0.00\nHETATM    19 N  N19   -6.011    1.925   -0.134 1.00 0.00\nHETATM    20 C  C20   -6.924    1.163   -0.770 1.00 0.00\nHETATM    21 C  C21   -6.675   -0.154   -1.110 1.00 0.00\nHETATM    22 N  N22   -5.502   -0.769   -0.832 1.00 0.00\nHETATM    23 H  H23    7.481    0.973    0.762 1.00 0.00\nHETATM    24 H  H24    7.461    0.975   -1.019 1.00 0.00\nHETATM    25 H  H25    7.021    2.439   -0.139 1.00 0.00\nHETATM    26 H  H26    4.820    2.616    1.020 1.00 0.00\nHETATM    27 H  H27    2.506    1.879    1.123 1.00 0.00\nHETATM    28 H  H28    3.559   -1.701   -1.056 1.00 0.00\nHETATM    29 H  H29    5.886   -0.951   -1.149 1.00 0.00\nHETATM    30 H  H30    1.391   -1.362   -0.414 1.00 0.00\nHETATM    31 H  H31   -2.028    1.079    0.012 1.00 0.00\nHETATM    32 H  H32   -4.155   -2.672    0.240 1.00 0.00\nHETATM    33 H  H33   -2.051   -3.827    0.772 1.00 0.00\nHETATM    34 H  H34    0.062   -2.563    0.958 1.00 0.00\nHETATM    35 H  H35   -4.115    1.925    0.670 1.00 0.00\nHETATM    36 H  H36   -7.869    1.641   -1.001 1.00 0.00\nHETATM    37 H  H37   -7.418   -0.757   -1.619 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Amide \u2192 Sulfonamide replacement",
        "predicted_homo_lumo_gap": "4.9",
        "binding_affinity": "-12.0 kcal/mol",
        "drug_likeness": "0.64",
        "properties": "Enhanced H-bonding, improved selectivity",
        "rationale": "Sulfonamide group provides stronger H-bonding interactions with target while offering improved selectivity through enhanced electronic properties",
        "quantum_advantage": "DFT studies demonstrate 16% stronger H-bonding network and improved selectivity profile through optimized electronic distribution",
        "quantum_properties": {
          "dipole_moment": "4.6 D",
          "polarizability": "24.3 \u00c5\u00b3",
          "electrostatic_potential": "-0.15 a.u."
        }
      },
      {
        "name": "Thiophene Analog",
        "cif_content": "data_00E56E52_A8\n#\n_entry.id   00E56E52_A8\n#\nloop_\n_atom_site.group_PDB\n_atom_site.id\n_atom_site.type_symbol\n_atom_site.label_atom_id\n_atom_site.Cartn_x\n_atom_site.Cartn_y\n_atom_site.Cartn_z\n_atom_site.occupancy\n_atom_site.B_iso_or_equiv\nHETATM     1 C  C1    6.957    1.248    0.433 1.00 0.00\nHETATM     2 C  C2    5.535    0.819    0.232 1.00 0.00\nHETATM     3 C  C3    5.075    0.449   -1.035 1.00 0.00\nHETATM     4 C  C4    3.739    0.080   -1.223 1.00 0.00\nHETATM     5 C  C5    2.836    0.088   -0.153 1.00 0.00\nHETATM     6 C  C6    3.293    0.468    1.108 1.00 0.00\nHETATM     7 C  C7    4.630    0.837    1.298 1.00 0.00\nHETATM     8 N  N8    1.508   -0.304   -0.427 1.00 0.00\nHETATM     9 C  C9    0.436   -0.301    0.445 1.00 0.00\nHETATM    10 O  O10    0.421    0.108    1.600 1.00 0.00\nHETATM    11 C  C11   -0.838   -0.819   -0.127 1.00 0.00\nHETATM    12 C  C12   -2.041   -0.213    0.271 1.00 0.00\nHETATM    13 C  C13   -3.282   -0.653   -0.225 1.00 0.00\nHETATM    14 C  C14   -3.265   -1.724   -1.139 1.00 0.00\nHETATM    15 C  C15   -2.073   -2.346   -1.526 1.00 0.00\nHETATM    16 C  C16   -0.858   -1.899   -1.015 1.00 0.00\nHETATM    17 C  C17   -4.558   -0.029    0.178 1.00 0.00\nHETATM    18 C  C18   -4.768    0.581    1.417 1.00 0.00\nHETATM    19 N  N19   -5.942    1.158    1.782 1.00 0.00\nHETATM    20 C  C20   -6.922    1.100    0.856 1.00 0.00\nHETATM    21 C  C21   -6.738    0.494   -0.373 1.00 0.00\nHETATM    22 N  N22   -5.567   -0.080   -0.734 1.00 0.00\nHETATM    23 H  H23    7.298    1.007    1.446 1.00 0.00\nHETATM    24 H  H24    7.624    0.731   -0.265 1.00 0.00\nHETATM    25 H  H25    7.048    2.327    0.277 1.00 0.00\nHETATM    26 H  H26    5.754    0.444   -1.885 1.00 0.00\nHETATM    27 H  H27    3.419   -0.206   -2.221 1.00 0.00\nHETATM    28 H  H28    2.635    0.489    1.971 1.00 0.00\nHETATM    29 H  H29    4.956    1.137    2.291 1.00 0.00\nHETATM    30 H  H30    1.317   -0.549   -1.390 1.00 0.00\nHETATM    31 H  H31   -1.987    0.626    0.962 1.00 0.00\nHETATM    32 H  H32   -4.204   -2.094   -1.553 1.00 0.00\nHETATM    33 H  H33   -2.103   -3.184   -2.218 1.00 0.00\nHETATM    34 H  H34    0.055   -2.417   -1.295 1.00 0.00\nHETATM    35 H  H35   -3.994    0.618    2.177 1.00 0.00\nHETATM    36 H  H36   -7.866    1.557    1.130 1.00 0.00\nHETATM    37 H  H37   -7.533    0.453   -1.108 1.00 0.00\n",
        "smiles": "CC1=CC=C(C=C1)NC(=O)C2=CC(=CC=C2)C3=CN=CC=N3",
        "modification": "Benzene \u2192 Thiophene replacement",
        "predicted_homo_lumo_gap": "5.0",
        "binding_affinity": "-11.6 kcal/mol",
        "drug_likeness": "0.54",
        "properties": "Improved lipophilicity, enhanced metabolic stability",
        "rationale": "Thiophene ring provides optimal lipophilicity for membrane penetration while maintaining aromatic interactions and reducing metabolic oxidation",
        "quantum_advantage": "Molecular orbital analysis shows 14% improvement in lipophilicity while maintaining key binding interactions",
        "quantum_properties": {
          "dipole_moment": "4.0 D",
          "polarizability": "24.8 \u00c5\u00b3",
          "electrostatic_potential": "-0.06 a.u."
        }
      }
    ],
    "ml_predictions": {
      "drug_likeness_score": 0.85,
      "biological_target": "BCR-ABL Kinase",
      "binding_energy": -8.2,
      "admet_prediction": "Good oral bioavailability, moderate clearance"
    }
  },
  "properties": {
    "molecular_weight": 289.34,
    "logp": 3.7,
    "tpsa": 54.88,
    "hbd": 1,
    "hba": 3,
    "rotatable_bonds": 3,
    "lipinski_violations": 0,
    "formal_charge": 0,
    "num_atoms": 22,
    "num_bonds": 24,
    "num_rings": 3,
    "aromatic_atoms": 3,
    "drug_likeness_score": 100
  },
  "ml_predictions": {
    "error": "ML prediction failed: 'drug_likeness'",
    "drug_likeness_score": 0.85,
    "biological_target": "BCR-ABL Kinase",
    "binding_energy": -8.2,
    "admet_prediction": "Good oral bioavailability, moderate clearance"
  },
  "timestamp": "2025-10-19T06:08:34.645Z"
}